The downgrade from Outperform to Neutral by a prominent analyst could lead to mixed reactions in the market. While the new price target of $161 suggests a potential upside, the downgrade itself may cause some investors to adopt a more cautious stance in the short term. The impact is considered neutral because the positive price target is balanced by the downgrade.